
Subsidiary Faces Drug License Suspension in Karnataka; Potential Revenue Loss Estimated at Rs 0.29 lacs
Medplus Health Services Limited has reported an order received by its subsidiary concerning the suspension of a Drug License for a store located in Karnataka.The action was taken against Optival Health Solutions Private Limited, a subsidiary of Medplus Health Services Limited. The Authority that passed the order is the Assistant Director of Drugs Control Administration, Vijayapura Circle, Vijayapura, Karnataka.
Details regarding the operational disruption and financial impact are as follows:
| Authority Name | Action Taken | Date of Receipt | Violation Basis | Financial Impact |
|---|---|---|---|---|
| Assistant Director, Drugs Control Administration, Vijayapura Circle, Vijayapura, Karnataka. | Suspension of Drug License for two days of a store located at Busstand Road Bijapur, Karnataka. | 25.07.2026 | Rule 65 of Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945 | Potential Revenue Loss of Rs 0.29 lacs. |
The suspension order relates to the Drug License for a store situated in the state of Karnataka. The potential revenue loss associated with this operational disruption has been quantified at Rs 0.29 lacs.
MEDPLUS Stock Price Movement
On Friday, shares of Medplus Health Services Limited rallied, settling at ₹720.55 after advancing 0.81% in trading. The stock finished with notable activity, recording a traded volume of 176,996 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.